4//SEC Filing
ARGOS THERAPEUTICS INC 4
Accession 0001293577-16-000002
CIK 0001105533operating
Filed
Jul 12, 8:00 PM ET
Accepted
Jul 13, 9:27 AM ET
Size
5.4 KB
Accession
0001293577-16-000002
Insider Transaction Report
Form 4
Katz Richard D
VP & Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2016-07-11+300,000→ 300,000 totalExercise: $6.30Exp: 2026-07-10→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]This option was granted on July 11, 2016 and vests as to 25% of the shares underlying this option on July 11, 2017, with the remaining 75% of the shares underlying this option vesting in equal amounts monthly over the next three years beginning July 11, 2017.
Documents
Issuer
ARGOS THERAPEUTICS INC
CIK 0001105533
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001105533
Filing Metadata
- Form type
- 4
- Filed
- Jul 12, 8:00 PM ET
- Accepted
- Jul 13, 9:27 AM ET
- Size
- 5.4 KB